A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Maruit Chulikavit, MPH
Advertisement
Articles by Maruit Chulikavit, MPH
Advertisement
Latest Updated Articles
- Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma
November 13th 2012
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
4
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
5